Articles

Involvement of cholinergic system in state-dependent learning induced by lithium in mice

Abstract

Objective:The influence of cholinergic drugs on lithium-induced statedependent learning has been investigated in adult male mice.
Method:
A single-trial step-down inhibitory avoidance task was selected. The drugs used in the study were lithium chloride physostigmine , nicotine hydrogen tartrate and scopolamine hydrobromide, atropine sulphate. The drugs were administrated through the peritoneal route. Control animals received saline or respective vehicle for nicotine. Ten animals were used in each experimental group. on day 1 or training session, the animals being trained in the step-down inhibitory avoidance task, and then immediately received post-training treatment of lithium or atropine or scopolamine. On day 2 or testing session, the animals firstly received pre-test administration of drugs (for nicotine 30 min, for lithium 45 min and for cholinergic antagonists 60 min before the test), and then were tested for step-down latency.
Results:The results showed that post-training and pre-test intraperitoneal (i.p.) administration of lithium (10 mg/kg) induced state-dependent learning. In addition, pre-test administration of an anticholinesterase, physostigmine (0.3 and 0.6 mg/kg, i.p.) and nicotinic acetylcholine receptor agonist, nicotine (0.1 and 0.5 mg/kg) could substitute for pre-test lithium. Pre-test coadministration of an ineffective dose of physostigmine (0.1 mg/kg) but not nicotine (0.01 mg/kg), with lower doses of lithium (2.5 and 5 mg/kg) potentiated the effect of the latter drug on step-down latency. Post-training administration of a nonselective antagonist of muscarinic acetylcholine receptors, atropine, decreased the step-down latency, but pre-test administration of the same dose of the drug and also lithium, could not reverse the decrease of step-down latency. On the other hand, pre-test atropine at higher doses (0.3 and 0.6 mg/kg) disrupted lithium-induced statedependent learning. On the contrary, the decrease of step-down latency due to post-training administration of another nonselective muscarinic antagonist, scopolamine (1 mg/kg, i.p.) reversed by pre-test administration of not only the same dose of the drug, but also lithium (10 mg/kg). Interestingly, pre-test administration of scopolamine (1 mg/kg) also reversed the decrease of stepdown latency induced by post-training lithium (10 mg/kg).
Conclusion:
cholinergic system(s) may be involved in the lithium-induced state- dependent learning and the involvement of muscarinic receptors is more possible than nicotinic ones.

Nierenberg AA, Price LH, Charney DS,Heninger GR. After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depression. J Affect Disord 1990; 18: 167-175.

Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithiumcarbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41: 1096-1104.

Chuang DM. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Crit Rev Neurobiol 2004; 16: 83-90.

Chuang DM. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 2005; 1053: 195-204.

Nonaka S, Katsube N,Chuang DM. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998; 286: 539-547.

Abrahamson JR. Use of lithium to control drug abuse. Am J Psychiatry 1983; 140: 1256.

Jasinski DR, Nutt JG, Haertzen CA, Griffith JD,Bunney WE. Lithium: effects on subjective functioning and morphine-induced euphoria. Science 1977; 195: 582-584.

Bone S, Roose SP, Dunner DL,Fieve RR. Incidence of side effects in patients on long- term lithium therapy. Am J Psychiatry 1980; 137: 103-104.

Honig A, Arts BM, Ponds RW,Riedel WJ. Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. Int Clin Psychopharmacol 1999; 14: 167-171.

Kocsis JH, Shaw ED, Stokes PE, Wilner P, Elliot AS, Sikes C, et al. Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol 1993; 13: 268-275.

Pachet AK,Wisniewski AM. The effects of lithium on cognition: an updated review. Psychopharmacology (Berl) 2003; 170: 225- 234.

Stip E, Dufresne J, Lussier I,Yatham L. A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. J Affect Disord 2000; 60: 147-157.

Tsaltas E, Kontis D, Boulougouris V, Papakosta VM, Giannou H, Poulopoulou C, et al. Enhancing effects of chronic lithium on memory in the rat. Behav Brain Res 2007; 177: 51-60.

Lim KY, Yang JJ, Lee DS, Noh JS, Jung MW,Chung YK. Lithium attenuates stress- induced impairment of long-term potentiation induction. Neuroreport 2005; 16: 1605-1608.

Furey ML, Pietrini P, Haxby JV, Alexander GE, Lee HC, VanMeter J, et al. Cholinergic stimulation alters performance and task- specific regional cerebral blood flow during working memory. Proc Natl Acad Sci U S A 1997; 94: 6512-6516.

Lerer B,Stanley M. Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain. Brain research 1985; 344: 211-219.

Lerer B,Stanley M. Does lithium stabilize muscarinic receptors? Biol Psychiatry 1985; 20: 1247-1250.

Winkler J, Suhr ST, Gage FH, Thal LJ,Fisher LJ. Essential role of neocortical acetylcholine in spatial memory. Nature 1995; 375: 484-487.

Lerer B. Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry 1985; 20: 20-40.

Bartus RT, Dean RL, 3rd,Beer B. Neuropeptide effects on memory in aged monkeys. Neurobiology of aging 1982; 3: 61- 68.

Bartus RT, Dean RL, 3rd, Beer B,Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-414.

Bymaster FP, Felder C, Ahmed S,McKinzie D. Muscarinic receptors as a target for drugs treating schizophrenia. Current drug targets 2002; 1: 163-181.

Bymaster FP,Felder CC. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Mol Psychiatry 2002; 7 S57-63.

Ebstein RP, Hermoni M,Belmaker RH. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther 1980; 213: 161-167.

Lenox RH,Hahn CG. Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry 2000; 61 Suppl 9: 5-15.

Manji HK, Chen G, Hsiao JK, Risby ED, Masana MI,Potter WZ. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy. J Clin Psychiatry 1996; 57 Suppl 13: 34-46; discussion 47-38.

Manji HK, Potter WZ,Lenox RH. Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry 1995; 52: 531-543.

Zarrindast MR, Lahmi A,Ahmadi S. Possible involvement of ยต-opioid receptors in effect of lithium on inhibitory avoidance response in mice. J Psychopharmacol 2008; In Press.

Zarrindast MR, Shendy MM,Ahmadi S. Nitric oxide modulates state dependency induced by lithium in an inhibitory avoidance task in mice. Behav Pharmacol 2007; 18: 289-295.

Zarrindast MR, Misaghi S,Ahmadi S. The dopaminergic system plays a role in the effect of lithium on inhibitory avoidance memory in mice. Eur J Pharmacol 2008; 590: 198-203.

Zarrindast MR, Parsaei L,Ahmadi S. Repeated Administration of Histamine Improves Memory Retrieval of Inhibitory Avoidance by Lithium in Mice. Pharmacology 2008; 81: 187-194.

Overton DA. Historical context of state dependent learning and discriminative drug effects. Behav Pharmacol 1991; 2: 253-264.

Shulz DE, Sosnik R, Ego V, Haidarliu S,Ahissar E. A neuronal analogue of state- dependent learning. Nature 2000; 403: 549- 553.

Bruins Slot LA,Colpaert FC. Opiate states of memory: receptor mechanisms. J Neurosci 1999; 19: 10520-10529.

Bruins Slot LA,Colpaert FC. Recall rendered dependent on an opiate state. Behav Neurosci 1999; 113: 337-344.

Castellano C. Effects of morphine and heroin on discrimination learning and consolidation in mice. Psychopharmacologia 1975; 42: 235- 242.

Izquierdo I,Dias RD. Effect of ACTH, epinephrine, beta-endorphin, naloxone, and of the combination of naloxone or beta-endorphin with ACTH or epinephrine on memory consolidation. Psychoneuroendocrinology 1983; 8: 81-87.

Colpaert FC, Koek W,Bruins Slot LA. Evidence that mnesic states govern normal and disordered memory. Behav Pharmacol 2001; 12: 575-589.

Jafari MR, Zarrindast MR,Djahanguiri B. Influence of cholinergic system modulators on morphine state-dependent memory of passive avoidance in mice. Physiol Behav 2006; 88: 146-151.

Zarrindast MR, Fazli-Tabaei S, Ahmadi S,Yahyavi SH. Effect of lithium on morphine state-dependent memory of passive avoidance in mice. Physiol Behav 2006; 87: 409-415.

Darbandi N, Rezayof A,Zarrindast MR. Modulation of morphine state-dependent learning by muscarinic cholinergic receptors of the ventral tegmental area. Physiol Behav 2008; 94: 604-610.

Rezayof A, Alijanpour S, Zarrindast MR,Rassouli Y. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors. Neurobiol Learn Mem 2008; 89: 441-447.

43Porcel J,Montalban X. Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis. J Neurol Sci 2006; 245: 177-181.

Roland JJ, Mark K, Vetreno RP,Savage LM. Increasing hippocampal acetylcholine levels enhance behavioral performance in an animal model of diencephalic amnesia. Brain Res 2008; 1234: 116-127.

Rezvani AH,Levin ED. Cognitive effects of nicotine. Biol Psychiatry 2001; 49: 258-267.

Rush DK. Scopolamine amnesia of passive avoidance: a deficit of information acquisition. Behav Neural Biol 1988; 50: 255-274.

Quirarte GL, Cruz-Morales SE, Cepeda A, Garcia-Montanez M, Roldan-Roldan G,Prado- Alcala RA. Effects of central muscarinic blockade on passive avoidance: anterograde amnesia, state dependency, or both? Behav Neural Biol 1994; 62: 15-20.

Petersen RC. Scopolamine state-dependent memory processes in man. Psychopharmacology (Berl) 1979; 64: 309- 314.

Files
IssueVol 3 No 3 (2008) QRcode
SectionArticles
Keywords
Atropine Learning Lithium chloridel Mice Nicotine Physostigmine Scopolamine

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Toosi V, Mollahasani F, Zarrindast M-R, Ahmadi S. Involvement of cholinergic system in state-dependent learning induced by lithium in mice. Iran J Psychiatry. 1;3(3):83-89.